Impact of cell saver during cardiac surgery on blood transfusion requirements: a systematic review and meta-analysis.

Murtadha K Al-KhaboriArwa Al RiyamiMohammad Salman SiddiqiZiyab Khan SarfarazEdem ZiadinovHilal Al Sabti

Published in: Vox sanguinis (2019)

The use of CS during cardiac surgery does not have an impact on the rates of RBC, platelet and FFP transfusion; however, this should be interpreted in the light of the study limitations.

Keyphrases

cardiac surgery
acute kidney injury
single cell
cell therapy
red blood cell
sickle cell disease